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Dynamic contrast-enhanced MRI in inﬂammatory arthritis, especially in conjunction with computer-aided analysis using
appropriate dedicated software, seems to be a highly sensitive tool for monitoring the early inﬂammatory treatment response
in patients with rheumatoid arthritis. This paper gives a review of the current knowledge of the emerging technique. The potential
of the technique is demonstrated and discussed in the context of a case report following the early eﬀect of an intra-articular steroid
injection in a patient with rheumatoid arthritis ﬂare in the knee.
1.Background
Imaging modalities aiming to identify perfusion character-
istics in inﬂammatory joint disease are receiving increas-
ing attention after results from a recent publication have
shown that measures of perfusion detected with ultrasound
Doppler in the wrist joints of rheumatoid arthritis patients
with low disease activity scores (DAS28) had the highest
p r e d i c t i v ev a l u eo ff u t u r ee r o s i v eo u t c o m e[ 1]c o m p a r e dt o
both clinical measures and conventional contrast enhanced
MRI.
dynamic contrast-enhanced MRI (DCE-MRI) is such
an imaging technique based on sequential acquisition of
rapid MRI sequences before and during the infusion of a
contrast agent. It can be used to evaluate synovial activity in
patients with rheumatoid arthritis (RA) and has been shown
to correlate closely to synovial vascularity and inﬂammation
[2–4]. An enhancement curve is obtained, where the initial
rate of enhancement and the resulting plateau and poten-
tial washout depends on the inﬂammatory vasodilation,
neoangiogenesis, and perfusion. The early enhancement rate
determined by DCE-MRI has shown to be more sensitive
to change after intraarticular steroid injection [5] and has
a closer relation to histological inﬂammatory activity than
measures of the synovial volumes [4, 6], making DCE-MRI a
promising tool for assessing the early inﬂammatory response
to treatment, potentially even before volume changes, and
thus changes in the semiquantitative synovitis score occur
[7].
DC E - M R Ih a sb e e nt e s t e do nl o w - ﬁ e l d[ 8] and high-ﬁeld
[4, 6] scanners and is capable of discriminating patients with
clinically active disease from those in remission.
Conventionally, DCE-MRI data is analysed using region
of interest- (ROI-) based technique, where a small, few2 Arthritis
millimetre ROI is placed in the most enhancing part of
the synovium, as perceived by an observer [8]. It has been
shown that the size and position of ROI have a great
impact on diagnostic accuracy and ROI misplacement by
only a few millimetres might give a 20%–30% diﬀerence in
the results [9]. Thus, ROI-based methods generate highly
subjective and potentially unreliable results. Finally DCE-
MRI data is inﬂuenced by micromovements of the imaged
joint introducing artifactual enhancement, which results in
large variation in the mean dynamic curves obtained by the
ROI method [10].
These issues have been addressed by application of a
new technique for analysis of dynamic data developed by
Kubassova et al. [11, 12]. This approach is based on a
fully automatic voxel- and model-based analysis technique
with built-in movement correction, which improves signal
to noise ratio up to 3-fold by taking out inter-scan patient
motion artefacts. Application of this technique for analysis
of dynamic data can solve most of the above-mentioned
technical issues, making DCE-MRI a more robust and even
more promising tool for assessing the early response of
inﬂammation to treatment.
2.Objective
To use DCE-MRI data to monitor early changes in param-
eters of knee joint inﬂammation in a patient with a ﬂair of
RA following ultrasound-guided intra-articular injection of
glucocorticoid (methylprednisolone acetate 40mg/ml). The
casewillserveasanexampleofthetechniqueandthechanges
seen will be discussed and explained in detail in order to give
the reader a better understanding of the potential and pitfalls
ofusingcomputer-aidedanalysisofDCE-MRIdata.Wehope
that this paper could serve as an example of the potential of
this methodology that can be further investigated in future
larger studies.
3.Case
3.1. Clinical Information. This 52-year-old lady was aﬀected
by seropositive RA diagnosed 13 years before. The patient
had side eﬀects with several DMARDs, including methotrex-
ate and was treated with prednisolone, 5mg daily. Sup-
plementary injections of methylprednisolone were given
occasionally in joints with acute ﬂares; the last intra-articular
injectionwasperformedinawristjoint10monthsbeforethe
present treatment.
Clinical ﬁndings at baseline included a moderately
swollen knee and slight-to-moderate joint pain with a
100mm visual analogue scale of pain of 30mm at rest and
50mm on joint movement.
Joint aspiration yielded 25cc of clouded synovial ﬂuid,
and after arthrocenthesis, 1.5ml glucocorticoid methypred-
nisolone 40mg/ml was injected in the lateral recess of the
knee with almost complete resolution of symptoms within
day 2 of injection and complete clinical remission at day
7. The eﬀect lasted for 2 months. The patient had normal
kidneyfunctionmeasuredbyserumcreatinineandestimated
glomerural ﬁltration rate (e-GFR).
3.2. Imaging. After informed and written consent, the
patient had conventional static MRI as well as dynamic MRI
performed on day 0, 1, 2, and 7 using a 0.2 T musculo-
skeletal extremity scanner (Esaote E-scan). The patient was
examined in supine position with the knee positioned
centrally in the receive-only cylindrical solenoid knee coil.
The following pulse sequences were applied: gradient-echo
scout, sagittal STIR (TR/TE/TI: 1310/24/85, fov/matrix:
200×170mm/192×163, slice thickness 4mm) and axial
3D T1 gradient echo (TR/TE: 38/16, fov/matrix: 180×180×
100mm/192×160×72, slice thickness 0.8 mm). After
these images were acquired, an intravenous injection of
0.1mmol/kg body weight Gadolinium-DTPA (Magnevist,
Schering AG, Berlin, Germany) was administered over a
period of 30 seconds. At the time of Gadolinium injection,
30 consecutive 5mm axial gradient echo dynamic MRI
(DCE-MRI) images (TR/TE 60/6, FOV/imaging matrix
160×160mm/256×128)inthreeprepositionedplaneswere
started and obtained every 10 second, covering the superior,
medial, lateral, and posterior joint recesses in the knee.
Image time was 300 seconds. Finally, the static axial 3D T1
gradient echo sequences were repeated. The acquisition time
of each sequence ranged from 4 to 8 minutes, with one signal
acquired. Total imaging time was 30 minutes.
3.3. Image Analysis. The conventional static imaging data
was displayed using an AGFA PACS system (Figures 1
and 4(c)-4(d)). The STIR sequence (Figure 1)w a su s e dt o
evaluate the bone marrow and eﬀusion. The pre- and post
contrast3DT1-wgradientechoimageswereusedtoevaluate
synovitis using a previously published semiquantitative
scores [7].
The dynamic enhancement pattern in the inﬂamed
knee synovium was analyzed using the software Dynamika-
RA (http://www.dynamika-ra.com/). Using this software,
we reduced patient motion artefacts between the dynamic
frames, which allowed reduction in artifactual enhancement,
thus increasing the SNR by a factor of 2 (data not shown).
The motion correction procedure took 3-4 minutes.
Further, the data was analysed using the voxel-by-voxel-
based approach, incorporated into the software, and the
enhancement characteristics of each voxel was computa-
tionally mapped to one of 4 enhancement models [13].
Parametric maps of the Gadolinium uptake pattern (Gd),
maximum enhancement (ME), initial rate of enhancement
(IRE),andtimeofonsetofenhancement(Figures2(a)–2(d))
are automatically calculated, and the corresponding colours,
representing the vessels perfusion and the synovial microcir-
culation, are superimposed on the gray scale dynamic pre-
contrast T1-weighted image. The colours in the Gadolinium
map reﬂect the behaviour of the Gadolinium over time,
where voxels with no gadolinium uptake have no colour;
voxels with persistent pattern of enhancement are shown in
blue; voxels with plateau in green and voxels with washout
pattern in red. In the ME and IRE maps, the most active
contrast enhancing voxels are displayed in white to yellow
colours,whereastissueswithlessperfusion/inﬂammationare
reddish (Figure 2)[ 13].Arthritis 3
Baseline
STIR
∗
∗
(a)
Day 2
STIR
∗
(b)
Figure 1: STIR images showing an evident signal decrease from the joint cavity between baseline and day two, corresponding to a reduced
joint eﬀusion. The eﬀusion in the images is marked with an asterix (∗).
3.4. Understanding the Dynamic Enhancement Maps. The
vertical colour bars or the Y-axis in the 4 enhancement maps
displaysthevaluesofthechosenparameter(ME,IRE,Tonset,
and Gd). The values are measured in each voxel, and then
grouped into 10 equally spaced bins. These are displayed on
the colour bar. ME shows the increase over a baseline in a
particular voxel and ME is measured as a ratio between the
baseline and the maximum enhancement of the enhance-
ment model calculated by the software program. The IRE
values show the increase in voxel intensity per second from
time onset to maximum enhancement is reached. Tonset is
measured in seconds and show the time in seconds, where
the enhancement curve begins compared to the ﬁrst baseline
frame. Gd washout-red, plateau-green, and persistent-blue
shows the pattern of enhancement in each particular voxel.
The horizontal colour bar shows the number of voxels
and their percentage of the total in ( ) for each statistic
in the corresponding IMAP, for example, 1 (0.01%) or 248
(91%), and so forth. For more information, visit http://www
.dynamika-ra.com/.
After the movement correction and the fully automatic
analysis of the knee joint was performed, several regions of
interest(ROIs)weredrawn(Figures3and4):(1)afastrough
box ROI around the anterior part of the knee including the
synovial membrane and excluding the major vessels; (2) a
box ROI around the popliteal artery in the posterior part
of the knee; (3) an oval ROI within the semimembraneous
muscle (Figure 4(a)). An example of the maps of ME, IRE,
and the corresponding static postcontrast 3D T1-w gradient
echo images over time after intra-articular steroid injection
are displayed in Figure 4. These maps serve as a guide to
visually evaluate the eﬀect of the steroid injection from
baseline through day 7.
4. Results
The conventional STIR images (Figure 1) showed an evident
signal decrease from the patients joint cavity between
baseline and day two and a smaller signal reduction in the
suprapatellar recess between day two and day 7. This signal
reduction may be ascribed to signiﬁcant decrease in joint
eﬀusion from a score of 2 to a score of 0 over time with
maximum eﬀect at day 7 [7]. Bone marrow oedema was
not present. The corresponding postcontrast T1-weighted
gradient echo images showed that the synovial enhancement
(arrows Figure 4(c)-4(d)) was unchanged corresponding to
a synovitis score of 1 [7] even though the volume of the
enhancing synovium was visually reduced on day 7 (image
not shown).
5.DCE-MRIData
5.1. Automatic Analysis. ME and IRE statistics, extracted
from the dynamic data of this case and generated for
the whole joint, showed no signiﬁcant changes in the
days following the steroid injection (Table 1). However, all
Gadolium-related parameters, such as the total number
of enhancing voxels (N-total), the number of voxels with
wash-out (N-washout), and plateau (N-plateau ) pattern of
enhancement, showed signiﬁcant changes before and after
treatment(Table 1).Incontrast,anincreaseofIREwasnoted
at day 7.
5.2. ROI Analysis. We further outlined a rough ROI posi-
tioned to include the synovial membrane and to exclude the
larger vessels especially behind the knee joint. There was no
need to position ROI precisely, as the measurements were
only done on the enhancing voxels inside the ROI (Figures
3 and 4).
The IRE of the roughly outlined synovial ROI decreased
from baseline values over the ﬁrst two days by a factor of 4
and stayed in the low end at 1-week followup. The mean ME
showed no signiﬁcant reduction (Table 1).
The dynamic curves and corresponding enhancement
statistics from the vessel ROI including the popliteal artery4 Arthritis
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Figure 2: Parametric maps derived from the same DCE-MRI dataset reﬂecting the Gadolinium behaviour and distribution over time (Gd),
maximum enhancement (ME), initial rate of enhancement (IRE), and time onset of enhancement (T-onset). The maps are derived from the
baseline images of the case study representing a ﬂair of moderate arthritis activity of the knee. Note the pulsation artefacts of the popliteal
artery that give false “hot” points in the image related to a horizontal line of the artery.
remained relatively unchanged over time but showed a day
to day variation (Table 1).
In order to normalize the ROI data, we multiplied the
sum of N-persistent and N-washout with the mean ME and
mean IRE in all ROIs. This gave a much clearer treatment
eﬀect in the data revealing a signiﬁcant reduction from base-
linethroughday7. Wesawaneﬀectev e no nda yo newiththe
mostpronouncedchangebetweendayoneandtwo(Table 1).
6. Discussion
When static post contrast T1 weighted MRI is used to
monitor, the early inﬂammatory treatment response in pa-
tients with RA a change of up to 30% in enhancing volume
is needed to imply a one step change in the inﬂammation
score [14]; accordingly, this method is relatively insensitive
to monitor the early treatment response upon anti inﬂam-
matory treatment.
In contrast, DCE-MRI seems to be highly sensitive to the
early treatment response, but even though the methodology
of DCE-MRI has been known for several years, previous
s t u d i e sh a v er e p o r t e dp r o b l e m sw i t hr e p r o d u c i b i l i t yo fr e -
sults due to large variations in the ROI analysis [9]. The
current case illustrates that DCE-MRI analysed using an ap-
propriatecomputersoftwareseemstobecapableofdetection
and quantiﬁcation of the very early treatment response and6 Arthritis
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Figure 3: A rough ROI outlining the anterior part of the knee in the dynamic image guided by the ME maps and their corresponding
dynamic curves from baseline through day 7 (a–d). Note the decrease of enhancing voxels in the parametric map over time as well as a
simultaneous decrease of the slope in the corresponding dynamic enhancement curves. The Y-axis of the enhancement curves shows the
intensity increase from baseline, and the X-axis shows the acquisition time in seconds.
that the observed changes upon treatment in this case occur
in parallel with changes in clinical symptoms. We have used
a single case to illustrate the potential of the technique, but
before ﬁnal conclusions concerning broader utility of this
method can be made, results from larger patient cohorts
are warranted, and there are some pitfalls and technical
challenges we need to understand as well.
Fully automated data analysis of the whole joint revealed
that the mean IRE and ME did not change signiﬁcantly
over time even though the number of enhancing voxels
showed a dramatic decrease between day 1 and 2. The
reason for this seems to be due to the confounding eﬀect
from the large vessels behind the knee, where the values
of ME and IRE are the highest; thus, the enhancement
changes in the synovial membrane are “shadowed” by the
activity in the neighbouring vessels. On the other hand,
making a rough ROI surrounding the synovial membrane,
and thus removing confounding inﬂuence from the major
blood vessels revealed a signiﬁcant treatment response in
the slope of the ROI curve that decreased by a factor of 4
between baseline and day 2 and remained in the same lower
range at one-week follow-up. Based on these observations,
we recommend to exclude the larger vessels from DCE-MRI
analysisofthekneejoint,whichcanbedonebyusingarough
ROI and an appropriate software tool.
The interpretation of changes in DCE-MRI following
intra-articular steroid administration is also potentially
confounded by the heterogeneity of treatment response
across the whole synovial tissue mass. Thus, as expected,
the ME did not change following treatment, since the
remaining voxels demonstrating enhancement in the follow-
up examinations reached approximately the same level as
observed in pretreatment images. However, it took a longer
time to achieve the plateau because of a lower steepness
of the slope (Figure 3). In order to better interpret the
changesin DCE-MRIimagesto reﬂectatruebiological eﬀect
of treatment intervention, despite the regional variation in
synovial responses which account for the lack of change
in ME in the ROI as a whole, we normalized the data by
multiplyingthemeanofMEandIREbythenumberofvoxels
with plateau and washout pattern of enhancement. This
permitted a much clearer statistical diﬀerentiation between
the data acquired before and after the treatment. In our
experience, all voxels, which reached the plateau or wash-
out phase, seem to represent the areas with synovial and
vessel perfusion, and we have chosen to use the sum of N-
plateau and N-washout in this normalisation. In contrast,
those tissues with a persistent pattern of enhancement (N-
persistent) are often located in the skin area or are due to
very ﬁne movement artefacts that were not removed by the
motion reduction algorithms. Whether this approach can be
used in general needs to be clariﬁed in larger studies.
As the software uses a model-based enhancement clas-
siﬁcation, there is no need to apply a threshold, nor do we
recommend to normalise the data to the enhancement char-
acteristicsof thevessels or themuscles, becausethereseemto
be a relative large day to day variation in the ROI statistics.
We have examined the current patient 4 times within
a week to measure the eﬀect of the steroid injection. This
approachcannotberecommendedforroutineclinicalusefor
manyreasons,includingtheuseofi.vGadolinium,expensive
and time-consuming MRI examinations, availability of MRI
scannersforRApatients.Thecaseshouldbeseenasanexam-
ple of the potential of the technique, but based on our resultsArthritis 7
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Figure 4: Parametric maps derived from DCE-MRI data maximum enhancement (ME) (a, b) and the corresponding static postcontrast 3D
T1-w gradient echo images (c, d) from baseline and day 2. Arrows pointing at the enhancing synovial membrane in the post contrast images
(c, d). Examples of the applied ROIs are shown in red in (a) representing the synovial ROI in front of the knee, the popliteal artery ROI
behind the knee, and the muscle ROI (oval circle).
which have to be conﬁrmed in larger studies, we speculate
that there could be a beneﬁt of using the technique to get a
more objective idea of the early treatment eﬀect of the more
expensive biologic treatments, that is, within 2–4 weeks of
treatment, which could lead to better patient care by reduc-
ingthetimespendonanineﬀectivetreatmentandinthelong
run money could be saved on the health economy budget.
This study has several limitations, as our ﬁndings are
based on a case report, and we have used the knee joint to
illustrate the potential of the technique, where ROI-based
exclusionofthelargervesselsisfairlyeasy.Wecannotassume
that our ﬁndings can be extrapolated to smaller and more
complex joints like the wrist. The therapeutic intervention
employed in this case was an intraarticular steroid injection
known to have a potent anti-inﬂammatory activity, and we
cannot assume that an observable treatment eﬀect would
be as pronounced and as rapid when using conventional
DMARDS or even biologic therapies.
7. Conclusion
In conclusion, DCE-MRI in conjunction with analysis using
appropriate software seems to be a highly sensitive tool for
monitoring the early inﬂammatory treatment response in8 Arthritis
patients with RA, as demonstrated by the assessment of a
knee joint inﬂammation following an intra-articular steroid
injection. The decrease in IRE and ME at day two follow-
up in this case example, especially seen in the normalized
data, corresponded to improvement in the patient’s clinical
symptoms. These ﬁndings have to be further tested in
larger clinical trials on several joints to see whether the
observed beneﬁt in the current case using dynamic MRI
may be used in general as a sensitive biomarker to track
the early treatment response in patients starting potent
anti-inﬂammatory treatments such as local/systemic steroid,
and/or biologics.
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